Table 2.

Study participant characteristics (n=71)

Characteristic	Study 1 (n=40)	Study 2 (n=31)	Total (n=71)
Age
18–24	5 (12%)	1 (3%)	6 (8%)
25–34	5 (12%)	4 (13%)	9 (13%)
35–44	12 (30%)	7 (23%)	19 (27%)
45–54	9 (23%)	6 (19%)	15 (21%)
55–64	4 (10%)	11 (35%)	15 (21%)
65–75	5 (13%)	2 (6%)	7 (10%)
Sex/Gender
Female Woman	31 (77%)	22 (71%)	53 (75%)
Male Man	7 (18%)	9 (29%)	16 (23%)
Genderqueer/Nonbinary/Transgender	2 (5%)	0	2 (1%)
Race*
American Indian/Alaskan Native	4 (10%)	3 (10%)	7 (10%)
Asian	3 (7%)	1 (3%)	4 (6%)
Black or African American	9 (23%)	6 (19%)	15 (21%)
Native Hawaiian/Pacific Islander	1 (2%)	-	1 (1%)
White	27 (67%)	18 (58%)	45 (63%)
Other	1 (2%)	4 (13%)	5 (7%)
Prefer not to answer	1 (2%)	0	1 (1%)
Ethnicity
Hispanic	9 (23%)	6 (19%)	15 (21%)
Migraine Type
Episodic	20 (50%)	18 (58%)	38 (53%)
Chronic	20 (50%)	13 (42%)	33 (47%)
Education
Completed high school	3 (8%)	1 (3%)	4 (6%)
Some college/technical school	18 (45%)	6 (19%)	24 (34%)
Completed college	11 (27%)	12 (39%)	23 (32%)
More than college	8 (20%)	12 (39%)	20 (28%)
Employment*
Paid employment	22 (55%)	20 (64%)	42 (59%)
Student	8 (20%)	2 (6%)	10 (14%)
Homemaker	3 (8%)	2 (6%)	5 (7%)
Retired	6 (15%)	3 (10%)	9 (13%)
Unemployed	2 (5%)	1 (3%)	3 (4%)
Disabled (or on disability or leave of absence)	10 (25%)	10 (32%)	20 (28%)
Other	1 (2%)	-	1 (1%)
Used any OTC or Prescription Acute Treatments in Prior Year
Yes	40 (100%)	30 (97%)	70 (98%)
No	-	1 (3%)	1 (1.5%)
Used any OTC or Preventive Treatments in Prior Year
Yes	35 (87%)	28 (90%)	63 (89%)
No	5 (8%)	3 (10%)	8 (11%)
Use Opioids/Barbiturates
Yes	3 (7%)	5 (16%)	8 (11%)
No	37 (9%)	26 (84%)	63 (89%)

^*Participants were able to select more than one race or employment status.

OTC = over the counter